Financial Insights’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,556	Closed	-$249K	–	154
2023 Q1	$249K	Sell	2,556 -2,267	-47%	-$220K	0.1%	149
2022 Q4	$499K	Buy	4,823 +2,076	+76%	+$215K	0.24%	81
2022 Q3	$233K	Buy	+2,747	New	+$233K	0.16%	107